Endothelial Progenitor Cells Give Rise to Pro-angiogenic Smooth Muscle-like Progeny
Overview
Authors
Affiliations
Aims: Reciprocal plasticity exists between endothelial and mesenchymal lineages. For instance, mature endothelial cells adopt a smooth muscle-like phenotype through transforming growth factor beta-1 (TGFbeta1)-driven endothelial-to-mesenchymal transdifferentiation (EndMT). Peripheral blood contains circulating endothelial progenitor cells of which the endothelial colony-forming cells (ECFCs) harbour stem cell-like properties. Given the plasticity between endothelial and mesenchymal lineages and the stem cell-like properties of ECFCs, we hypothesized that ECFCs can give rise to smooth muscle-like progeny.
Methods And Results: ECFCs were stimulated with TGFbeta1, after which TGFbeta signalling cascades and their downstream effects were investigated. Indeed, EndMT of ECFCs resulted in smooth muscle-like progeniture. TGFbeta1-driven EndMT is mediated by ALK5 kinase activity, increased downstream Smad2 signalling, and reduced protein levels of inhibitor of DNA-binding protein 3. ECFCs lost expression of endothelial markers and endothelial anti-thrombogenic function. Simultaneously, mesenchymal marker expression was gained, cytoskeletal rearrangements occurred, and cells acquired a contractile phenotype. Transdifferentiated ECFCs were phenotypically stable and self-sustaining and, importantly, showed fibroblast growth factor-2 and angiopoietin-1-mediated pro-angiogenic paracrine properties.
Conclusion: Our study is the first to demonstrate that ECFCs can give rise to smooth muscle-like progeny, with potential therapeutic benefits. These findings further illustrate that ECFCs are highly plastic, which by itself has implications for therapeutical use.
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies.
Karakasis P, Theofilis P, Patoulias D, Vlachakis P, Antoniadis A, Fragakis N Int J Mol Sci. 2025; 26(5).
PMID: 40076813 PMC: 11900163. DOI: 10.3390/ijms26052196.
Ching P, Chang Y, Weng C, Wang J, Yeh M ACS Omega. 2025; 10(8):8523-8537.
PMID: 40060830 PMC: 11886913. DOI: 10.1021/acsomega.4c10829.
Li C, Pan Y, Wang Y, Li X, Tie Y, Li S Cell Mol Life Sci. 2025; 82(1):50.
PMID: 39833543 PMC: 11747068. DOI: 10.1007/s00018-024-05572-x.
Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches.
Khan A, Jandeleit-Dahm K Nat Rev Cardiol. 2025; .
PMID: 39805949 DOI: 10.1038/s41569-024-01115-w.
Evaluation of Antibodies for Vascular Smooth Muscle Cell Characterization.
Shen E, Salmeron L, Sanchez G, McCloskey K Stem Cell Regen Med. 2024; 8(1).
PMID: 39512442 PMC: 11542737.